CytoSorbents receives Nasdaq delisting notice for bid price below $1.00

Cytosorbents Corp

Received Nasdaq notice on May 20, 2024 for non-compliance with Minimum Bid Price Requirement.
Has 180 calendar days, until November 16, 2024, to regain compliance.
To regain compliance, closing bid price must be $1.00 or more for 10 consecutive business days.
If not compliant by deadline, Nasdaq will provide delisting notice; Company may appeal.
Company intends to monitor and consider options, but no assurance of compliance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.